Zillow Group Prices Offering of $400 Million of 2.00% Convertible Senior Notes
Dec 07, 2016 14:00 pm UTC| Business
SEATTLE, Dec. 07, 2016 -- Zillow Group, Inc. (NASDAQ:Z) (NASDAQ:ZG) announced today the pricing of its offering of $400.0 million aggregate principal amount of 2.00% Convertible Senior Notes due 2021 (the “Convertible...
Customers Bancorp, Inc. Achieves Market Capitalization of $1 Billion
Dec 07, 2016 14:00 pm UTC| Business
WYOMISSING, Pa., Dec. 07, 2016 -- Customers Bancorp, Inc. (NYSE:CUBI), the parent company of Customers Bank (collectively referred to as "Customers" or the “Company”), today reported that the Company achieved a market...
Dec 07, 2016 14:00 pm UTC| Business
JUST Capitalpartners with GoodData® to create the foundation and single source of truth to identify JUST companies. With multiple disparate data sources and the need to manage complex data transformation, JUST Capital...
Five Star Bank Names Craig Burton Senior Vice President, Commercial Real Estate Executive
Dec 07, 2016 14:00 pm UTC| Business
WARSAW, N.Y., Dec. 07, 2016 -- Five Star Bank (“Five Star” or the “Bank”), subsidiary of Financial Institutions, Inc. (NASDAQ:FISI), today announced the hiring of Craig Burton as Senior Vice President, Commercial Real...
Xively Sets the Bar for IoT Scale & Performance; Leading Analyst Firm Finds
Dec 07, 2016 14:00 pm UTC| Business
BOSTON, Dec. 07, 2016 -- Today Xively by LogMeIn, Inc. (NASDAQ:LOGM) and Enterprise Strategy Group (ESG), a leading IT analyst, research, validation, and strategy firm released the results of an IoT scalability...
Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion
Dec 07, 2016 13:51 pm UTC| Business
PLAINSBORO, N.J., Dec. 07, 2016 -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. The expanded and...
NeuroDerm Announces Pricing of a Follow-On Offering of Ordinary Shares
Dec 07, 2016 13:50 pm UTC| Business
REHOVOT, Israel, Dec. 07, 2016 -- NeuroDerm Ltd. (NASDAQ:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced the pricing of a follow-on offering of...